
About Synaptic Systems
Synaptic Systems is a company based in Gottingen (Germany) founded in 1997. The company has 29 employees. Synaptic Systems offers products and services including Primary Antibodies, Secondary Antibodies, and FluoTags. Synaptic Systems operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Employee Count29
Products & Services of Synaptic Systems
Synaptic Systems offers a comprehensive portfolio of products and services, including Primary Antibodies, Secondary Antibodies, and FluoTags.
Antibodies for detecting specific proteins in life science research.
Antibodies used in detection for assays like Western blot.
Camelid single domain antibodies for fluorescent labeling in research.
People of Synaptic Systems
1 people are tracked at Synaptic Systems (1 in leadership); the tracked headcount is 29.
| Name | Role | Group |
|---|---|---|
Selwyn Herring | CEO & MD | Leadership |
Complete people profiles for Synaptic Systems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Synaptic Systems
Synaptic Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | – | Monoclonal antibody technology and products are developed by Epitomics. | |
| ybiologics.com | 2007 | Daejeon, South Korea | $42.1M | – | Developer of antibodies for the treatment of multiple diseases | |
| mabtech.com | 1986 | Nacka, Sweden | – | – | Antibodies and immunoassay kits are developed for research applications. | |
| opmbiosciences.com | 2013 | Pudong, China | $14.42M | – | Antibody and vaccine culture media products are developed. | |
| itb-med.com | 2016 | Stockholm, Sweden | $87M | – | Monoclonal antibodies are developed to prevent transplant rejections. | |
| abrevbio.com | 2018 | Nanjing, China | $90M | – | Antibody-drug development platforms are provided for life sciences research. | |
| vectorlabs.com | 1976 | Burlingame, United States | – | – | Labeling and detection reagents immunohistochemistry studies and other life science research applications | |
| allelebiotech.com | 1999 | San Diego, United States | $18M | – | Nano-antibodies, iPSCs, fluorescent proteins, and RNAi are developed. |
Detailed competitors of Synaptic Systems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synaptic Systems
The website of Synaptic Systems (sysy.com) receives about 55.8K visits a month.
- Monthly visits55.8K
▲ 46.4% vs previous month
Websites whose visitors overlap most with Synaptic Systems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nano-tag.com | 100% | 9K | #2,274,949 | View details | |
| antibodiesinc.com | 100% | 21K | #1,321,745 | View details | |
| abcam.com | 96% | 602.8K | #91,958 | View details | |
| antibodies-online.com | 95% | 57.4K | #648,443 | View details | |
| immunostar.com | 93% | – | #4,473,909 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Synaptic Systems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Synaptic Systems
10 companies that operate in the same segment as Synaptic Systems (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synaptic Systems
Synaptic Systems was founded in 1997.
Synaptic Systems is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.
Selwyn Herring is the current CEO of Synaptic Systems.
Synaptic Systems has 29 employees.
Synaptic Systems was founded in 1997 in Gottingen, Germany, as a biotech firm focused on synaptic proteins. Polyclonal and monoclonal antibodies are developed and produced, including those licensed from scientists and created in-house. A large collection of such antibodies is maintained worldwide. Proprietary assays for monitoring vesicle recycling in synapse subpopulations are utilized, alongside expertise in applications like immunoblotting, immunofluorescence, ELISA, and immunoprecipitation.
Synaptic Systems's top competitors include Sino Biological, GenScript and Y-Biologics.
Synaptic Systems offers Primary Antibodies, Secondary Antibodies, and FluoTags.
Synaptic Systems operates through Synaptic Systems Gmbh.